Strong growth overshadowed by margin compression, capex on track
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade C
Capacity timelines on track (NBR April, SBR June), but margin guidance softened from 15-16% to ~12%.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong 48% YoY revenue growth with ₹220 Cr capex underway for NBR/SBR capacity (April-June). Key risk: EBITDA margins compressed to 11.7% despite volume growth; prior 15-16% guidance de facto cut to ~12%.
₹498.9 Cr
Revenue · +48.2% YoY₹34.8 Cr
Reported PAT · +37.7% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Q2 revenue ₹499 Cr, 48% YoY growth
MET₹498.9 Cr delivered, 48.2% YoY growth confirmed
PAT ₹35 Cr, 38% YoY growth
MET₹34.8 Cr delivered, 37.7% YoY growth
EBITDA margin 11.69%, down 37 bps YoY
METOPM 11.7% delivered; margin compression YoY confirmed
Inventory losses ~1.5% depressed margins
OVERSTATEDNo independent verification; explanation plausible but unquantified in results
7% volume growth achieved in Q2
METNot contradicted in delivered result; consistent with 48% revenue growth and deflation
Earnings quality
What changed since the last call
EBITDA margin guidance cut
DowngradeFrom 15-16% sustainable (prior) to ~12% (current expectation); market overcapacity and cost inflation cited
Nitrile expansion deferred
NeutralDecision delayed pending margin recovery trends in next 2-3 quarters; waiting for cost/pricing environment clarity
Long-term growth target added
UpgradeNew 10% CAGR guidance for next 3-5 years; 7% Q2 growth achieved; construction segment strong
The Q&A
Analysts pressed on margin compression; management defended with inventory losses explanation. Professional exchange, but margin recovery timeline unclear.
Margin compression — Aditya Khetan, SMIFS
Answered1.5% inventory loss from falling prices in Q2 H1; recovery expected as prices rose Oct-Nov. EBITDA per ton healthier than reported
CAPEX progress — Farrokh Pandole, Avestha
Answered₹65 Cr spent of ₹220 Cr total; ₹155 Cr to outflow. NBR online April '27, ramp 2-3 years. SBR also underway.
Segment performance — Karan, Credent
AnsweredConstruction strong, carpets lagging due to Middle East weakness. Overall expect 10-12% annual growth; well-positioned for MENA and Southeast Asia expansion
Volume growth outlook — Jasdeep Ahluwalia, Clockvine
AnsweredBullish; construction robust, carpets facing headwinds. Targeting 10% CAGR with population/GDP growth in India, Southeast Asia substitution from Europe
Nitrile expansion — Aditya Khetan, SMIFS
PartialWaiting 2-3 quarters to see margin trends; currently at 12%, ideally want 15%+. Overcapacity in market remains a concern from COVID era
Guidance
FY27 capex ₹220 Cr adds ~₹600 Cr incremental revenue
HighNBR and SBR capacity expansion; 40% incremental growth; H1 delivery tracking guidance run-rate
Sustainable EBITDA margins ~12% (down from 15-16% prior)
MediumCurrent market conditions with high raw costs, overcapacity limit near-term margins; management accepting 12% target
Total ₹220 Cr capex for NBR and SBR projects
High₹65 Cr spent, ₹155 Cr to outflow; on track for April-June commissioning; 2-3 year ramp expected
Risks the call surfaced
Carpet market weakness
HighCarpet segment dependent on Middle East/North Africa; facing volume losses. Domestic manufacturers also reliant on these markets. Structural headwind from overcapacity.
Input cost inflation
MediumGeopolitical supply disruptions driving higher raw material costs and shipping rates. Margin compression despite price pass-through suggests limited pricing power.
Capacity execution risk
Medium₹220 Cr capex for NBR and SBR expansion; timelines April-June '27. Delay or cost overrun would impact FY28 growth and margin recovery trajectory.
Synthetic latex overcapacity
MediumSynthetic latex facing structural overcapacity, particularly in carpets. Management considering nitrile expansion but deferring decision pending margin recovery. Overinvestment post-COVID still affecting industry.
Management
Score 7/10. Clear on strategy and market drivers; candid about challenges (carpet weakness, margin pressure, overcapacity). Withheld segment volumes citing proprietary reasons; acceptable but limits full transparency. On track with capex timelines (₹65 Cr of ₹220 Cr spent). H1 revenue growth of 44% YoY tracking guidance. Delivered on prior NBR/SBR timeline commitments. Operationally sound.
1 · Apr 2027
NBR capacity on stream; revenue ramp begins
2 · Jun 2027
SBR latex plant commissioned; adds incremental capacity
3 · H2 FY27
Margin recovery as inventory normalizes, prices stabilize
Key risk: EBITDA margins compressed to 11.7% despite volume growth; prior 15-16% guidance de facto cut to ~12%.
Informational and educational content only. Not investment advice.